Viewing Study NCT01422135


Ignite Creation Date: 2025-12-24 @ 10:31 PM
Ignite Modification Date: 2025-12-28 @ 7:17 AM
Study NCT ID: NCT01422135
Status: COMPLETED
Last Update Posted: 2018-12-31
First Post: 2011-08-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females
Sponsor: Agile Therapeutics
Organization:

Study Overview

Official Title: A Pharmacokinetic Study of the Agile TCDS AG200-15 Following Weekly Application to Three Anatomical Sites (Abdomen, Buttock and Upper Torso) in Healthy Female Volunteers
Status: COMPLETED
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a pharmacokinetics and safety study over 3 weekly applications.
Detailed Description: Pharmacokinetic study to evaluate the safety and pharmacokinetic profile of AG200-15 following application at three different anatomical sites (abdomen, buttock and upper torso).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: